neoadjuvant_thymic Epithelial Tumor
Clinical trial NCT03858582 · UNKNOWN
Trial details
- NCT number
- NCT03858582
- Sponsor
- Samsung Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-29
- Primary completion
- 2022-04-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.